Related Experiment Video
Updated: Apr 6, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells
Melania E Mercado-Pimentel1, Benjamin C Onyeagucha2, Qing Li3
1Department of Pathology, University of Arizona, Tucson, AZ 85724, USA; University of Arizona Cancer Center, Tucson, AZ, USA.
Abstract:
S100P signaling through the receptor for advanced glycation end-products (RAGE) contributes to colon cancer invasion and metastasis, but the mechanistic features of this process are obscure. Here, we investigate whether activation of S100P/RAGE signaling regulates oncogenic microRNA-21 (miR-21). We show that exogenous S100P up-regulates miR-21 levels in human colon cancer cells, whereas knockdown of S100P results in a decrease of miR-21. Furthermore, blockage of RAGE with anti-RAGE antibody suppresses S100P induction of miR-21. In addition, we found that S100P induction of miR-21 expression involves ERK and is suppressed by the MEK inhibitor U0126. Also, S100P treatment stimulates the enrichment of c-Fos, and AP-1 family members, at the miR-21 gene promoter.
Insights
S100P protein signaling activates microRNA-21 (miR-21) in colon cancer cells via the receptor for advanced glycation end-products (RAGE) and ERK pathways, promoting cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- S100P protein and its receptor for advanced glycation end-products (RAGE) pathway are implicated in colon cancer invasion and metastasis.
- The precise molecular mechanisms linking S100P/RAGE signaling to colon cancer progression remain largely unknown.
Purpose of the Study:
- To investigate the role of S100P/RAGE signaling in regulating the expression of the oncogenic microRNA-21 (miR-21) in human colon cancer cells.
- To elucidate the signaling pathways involved in S100P-mediated miR-21 upregulation.
Main Methods:
- Utilized human colon cancer cell lines.
- Assessed miR-21 levels following S100P stimulation and knockdown.
- Investigated the effect of RAGE blockade using an anti-RAGE antibody.
- Examined the involvement of the ERK/MAPK pathway using the MEK inhibitor U0126.
- Analyzed transcription factor binding at the miR-21 gene promoter using chromatin immunoprecipitation.
Main Results:
- Exogenous S100P administration increased miR-21 levels in colon cancer cells.
- Knockdown of S100P led to decreased miR-21 expression.
- Blocking RAGE with an antibody inhibited S100P-induced miR-21 upregulation.
- S100P-mediated miR-21 induction was dependent on the ERK signaling pathway.
- S100P treatment enhanced the binding of c-Fos and AP-1 transcription factors to the miR-21 gene promoter.
Conclusions:
- S100P signaling, through RAGE and the ERK pathway, upregulates oncogenic miR-21 in colon cancer.
- This S100P/RAGE/ERK/miR-21 axis represents a novel mechanism contributing to colon cancer progression.
- Targeting this pathway may offer therapeutic strategies for colon cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation

